FIELD: medicine.
SUBSTANCE: present invention relates to medicine, namely to oncology, and relates to cancer treatment. For this purpose efficient amount of DMXAA compound (5,6-dimetylxanthenon-4-acetic acid) in combination with inhibitors of signal pathway EGFR is introduced.
EFFECT: invention provides for efficient treatment as a result of synergetic antitumor effect of specified preparations.
26 cl, 2 tbl, 2 dwg
Authors
Dates
2010-11-27—Published
2006-08-25—Filed